Professor of Critical Care Medicine at the National Heart and Lung Institute and Consultant Physician at St Bartholomew's Hospital, London. Having qualified at London University in 1987, he was appointed as a consultant in 2002.
Clinical interests include ARDS, ICU acquired weakness, human models of ARDS and other aspects of critical illness, and extra-corporeal gas exchange techniques.
His research is focussed on cellular and molecular mechanisms of acute lung injury and repair. Current, focus of research is the effect of mechanical forces on lung injury and repair; current models include cellular stretch, in vivo murine ventilator-induced lung injury (with Prof Takata, SORA ICL), EVLP and surgical models of acute lung injury and multiple organ dysfunction. He is involved in multidisciplinary translational research which integrates basic science with clinical studies, thereby providing novel insights into critical illness.
et al., 2018, Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury, Thorax, Vol:73, ISSN:0040-6376, Pages:723-730
et al., 2018, Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza, Nature Immunology, Vol:19, ISSN:1529-2908, Pages:625-+
et al., 2018, miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting, Journal of Cachexia Sarcopenia and Muscle, Vol:9, ISSN:2190-6009, Pages:400-416
et al., 2018, miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss, Journal of Cachexia Sarcopenia and Muscle, Vol:9, ISSN:2190-6009, Pages:119-128
et al., 2017, MECHANISMS OF REGENERATION: RETINOIC ACID ACTS VIA THE ENDOTHELIUM TO DRIVE HUMAN LUNG REPAIR, Winter Meeting of the British-Thoracic-Society, BMJ PUBLISHING GROUP, Pages:A106-A107, ISSN:0040-6376